Research Report: By Type (Cyclic, Calcitonin Gene-Related, Caspase Related, Amyloid, Adrenomedullin, Amylin, Tau, Cosmetic, Anti-Microbial, GPCR), Application (Commercial, Academic Research, Therapeutics), End-User, Geographical Outlook (U.

New York, Jan. 29, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Catalog Peptides Market" - https://www.reportlinker.com/p05842937/?utm_source=GNW
S., Canada, Germany, France, U.K., Italy, Spain, China, Japan, India, South Korea, Singapore, Brazil, Mexico, Israel, South Africa, Saudi Arabia) - Global Industry Size, Share Analysis and Growth Forecast to 2024

The catalog peptides market is expected to grow to $332.1 million by 2024 at a CAGR of 5.8% during the forecast period (2019–2024), from $238.4 million in 2018. The increasing funding in protein-based research, technical advancements, rising chronic disease burden, and growing research activities to develop innovative therapies are the major drivers of the market. A short chain of amino acids, in which the amino acids are linked together by peptide bonds, constitutes a peptide. Catalog peptides are off-the-shelf products, which are available with manufacturers for use in biochemistry, molecular medicine, and pharmacology.

The catalog peptides market is observing growth due to advancements in technology that help in the cost-effective manufacturing of peptides. Previously, peptides were synthesized from natural sources, such as adrenocorticotropic hormone (ACTH) derived from the porcine or bovine pituitary and insulin from bovine or canine pancreas. The production of naturally synthesized peptides is not only time consuming, but also has low yield and is much more cost-intensive. With technical advancements, peptides, such as octreotide, oxytocin, leuprorelin, and vasopressin, can be synthesized using solid-phase synthesis.
The subdivisions of the catalog peptides market, based on type, are G protein-coupled receptor (GPCR), calcitonin gene-related, anti-microbial, caspase-related, tau, amyloid, amylin, adrenomedullin, and cyclic. Cyclic proteins contributed about 11.3% of the total revenue to the market in 2018. These peptides have diverse biological activities, such as immunosuppressive, antibacterial, and anti-tumor activities, which contributed in their significant market share. Owing to their wide-ranging application, cyclic peptides are predicted to be the leader in revenue generation during the forecast period too.

Asia-Pacific (APAC) can be the most lucrative region for the catalog peptides market to maximize revenue. A 2017 United Nations factsheet mentioned that the population above the age of 60 would double by 2050 across the globe. With the rising prevalence of chronic diseases, the demand for novel therapies is increasing for the proper management of such diseases. As the APAC region accounts for 60.0% of the world’s population, the demand for catalog peptides is expected to be high here. Further, low manufacturing costs and lenient regulations are inviting foreign investments.

Hence, the market for catalog peptides is slated to advance in the forecast period due to the rising chronic disease prevalence, increasing research activities, and technical advancements.
Read the full report: https://www.reportlinker.com/p05842937/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.